ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZINGO
Topical pain relief
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

REMOVE SELECTED | COMPARE SELECTED

Drug Name:

ZINGO Rx

Generic Name and Formulations:
Lidocaine HCl (as monohydrate) 0.5mg/device; pwd for intradermal inj.

Company:
Anesiva, Inc.

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for ZINGO:

To provide local analgesia prior to venipuncture or peripheral IV cannulation in children.

Adult Dose for ZINGO:

Not applicable.

Children's Dose for ZINGO:

<3 years: not recommended. 3–18 years: Use only on intact skin. Apply one 0.5mg dose to the planned procedure site 1–3 minutes before needle insertion; may repeat once at new site after initial attempt failed. Multiple administrations to same site: not recommended.

Pharmacological Class:

Local anesthetic.

Warnings/Precautions:

Avoid eyes, body orifices, mucous membranes or areas with a compromised skin barrier. Severe hepatic disease or pseudocholinesterase deficiency. Bleeding tendencies or platelet disorders: higher risk of superficial dermal bleeding. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Additive effects with other local anesthetics.

Adverse Reactions:

Application-site reactions (eg, erythema, petechiae, edema), systemic reactions (eg, nausea, vomiting).

How Supplied:

Single-use device (disposable, needle-free)—12